.jpg)
After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’
After having a day to read through the Supreme Court’s decision on affirmative action, some…
Author: STAT
Malaria cases in Florida and Texas: Here’s what you need to know
The five cases of malaria diagnosed in Florida and Texas in recent weeks — the…
Opinion: The Supreme Court’s affirmative action decision puts lives at risk
The past several months have been grim for health in the U.S. In December, the…
STAT+: Bright Health sells Medicare Advantage plans to Molina for $600 million
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded…
STAT+: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Medicare details the structure of its new drug price negotiation program
WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation…
Opinion: CMS must protect access to the ‘gold standard of breast reconstruction’
In 1983, I flew home from college to be with my mother as she woke…
For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost
Pat Furlong was sitting in her home office in Middletown, Ohio, last Thursday, refreshing a…
STAT+: Medicare’s new proposal to cover medical devices draws a mixed reaction
The medical device industry is split on whether a proposed new Medicare reimbursement pathway will…
STAT+: BioMarin wins approval for gene therapy to treat hemophilia A
The Food and Drug Administration on Thursday approved a gene therapy to treat people with…
Stop taking Ozempic before surgery, anesthesiologist group recommends
Patients fast before surgery to prevent food from getting into their lungs while they’re under…
Listen: Novavax’s CEO promises a turnaround & how Lilly roiled the obesity market
Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing…
Medical leaders decry Supreme Court decision on affirmative action
Medical leaders on Thursday reacted swiftly to the Supreme Court’s decision to severely restrict the…
We have a cure for hepatitis C — so why aren’t more people getting treatment?
In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years…
STAT+: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa
Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious…
STAT+: Former Pfizer statistician is charged with insider trading over Paxlovid clinical trial results
A former Pfizer statistician on Thursday was charged by U.S. authorities with insider trading for…
Supreme Court strikes down use of affirmative action, a blow to efforts to diversify medical schools
Overturning decades of precedent, the U.S. Supreme Court on Thursday struck down the use of…
STAT+: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection
Top of the morning to you. A delicious cool breeze and shiny sun are hovering…
STAT+: Drug wholesaler owner indicted for role in diverting Gilead and J&J HIV medicines
The owner of a pharmaceutical wholesaler has been indicted for his alleged role in distributing…
Opinion: The love my daughter and I found in the PICU
The ventilator alarm woke me at 3 a.m. It was the fourth alarm in the…
STAT+: Counter-culture or pharma: Group behind MDMA therapy for PTSD wrestles with its identity
DENVER — He could have been a rock star, a religious icon, the way ecstatic…
Walensky prepares to leave CDC — and Congress — after a bruising 29 months
Rochelle Walensky, the outgoing director of the Centers for Disease Control and Prevention, will miss…
STAT+: Trump demands the U.S. pay no more for drugs than other countries … again
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to…
A replacement for race: Medical experts explore how to eliminate bias in clinical algorithms
WASHINGTON — Most of the medical community has acknowledged that racism is baked into many…
Gates Foundation to launch trial of long-awaited new tuberculosis vaccine candidate
The Gates Foundation said Wednesday it plans to launch a long-awaited trial to test what,…
Opinion: Smoke from Canadian wildfires shows outdoor workers need air quality protections
In 20 states, people are once again breathing in hazardous smoke from Canadian wildfires. The…
STAT+: Pharmalittle: FDA declines to approve higher dose version of Regeneron eye drug; FDA warns wholesaler over counterfeit HIV pills
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Moonlake’s less-than-transparent data disclosures produced a cash windfall. Risks remain
For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from…
Opinion: Listen: Cancer drug shortages should be causing more outrage
Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer…
.jpg)
When young people survive cancer, their mental-health struggles are often just beginning
Thanks to advances in treatments, children’s chances of surviving cancer are higher than ever before….
STAT+: ‘It’s like Groundhog Day’: The cancer drug shortage isn’t new — and neither are the solutions
A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic…
Opinion: It’s past time to address the problem of indoor air quality. A new technology can help
Until the early 20th century, America regularly experienced brutally destructive urban fires. Conflagrations like the…
STAT+: Protestors slam health insurance lobby for Medicare Advantage coverage restrictions
WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest…
STAT+: FDA issues warning to wholesaler sued by Gilead and J&J for distributing counterfeit medicines
A year after two major drugmakers sued a wholesaler for its alleged role in distributing…
STAT unveils a new look, and color. Our executive editor explains why
Dear Readers, Today is an important day in the history of STAT: We have refreshed…
STAT+: After late start, Eli Lilly starts pulling ahead in race for the $30 billion weight loss market
SAN DIEGO — It was Novo Nordisk’s Ozempic and Wegovy that set off a new…
STAT+: Global controversy heats up the race to build human embryos from stem cells
Earlier this month, a British journalist broke the news that researchers had taken a major…
STAT+: Lilly reaches $2.4 million settlement with EEOC over age discrimination lawsuit
Eli Lilly agreed to pay $2.4 million as part of a settlement with the U.S….
STAT+: Pharmalittle: Lilly drug shows biggest weight loss yet in mid-stage trial; Biogen shareholders elect director’s romantic partner to the board
Top of the morning to you. The middle of the week is upon us and,…
For volunteers at an eating disorder hotline, being replaced by an AI chatbot carried a painful cost
Early this spring, dozens of volunteers fielding requests from people struggling with eating disorders —…
STAT+: Grail faces uphill battle to get Medicare to cover its cancer screening test
WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test…
Opinion: A seemingly small semantic issue is a major roadblock to develop treatments for rare diseases
Finding a new medicine is never easy. But developing treatments for patients with rare diseases…
STAT+: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?
The makers of minimally invasive surgical devices seemed poised to capture a wide swath of…
Opinion: CMS change could slow the crucial growth of ‘food as medicine’
Sometimes, an apple a day really is just what the doctor ordered. And for the…
STAT+: U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes
LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s…
STAT+: Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study
SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in…
STAT+: Illumina to lay off 10% of research and development team in bid to cut costs by $100 million
SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing…
Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial
SAN DIEGO — Ozempic and Wegovy became weight loss sensations by targeting a single hormone,…
STAT+: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys
Home health and hospice chain Amedisys has chosen a new corporate owner. Amedisys and UnitedHealth…
STAT+: Shareholders elect director’s romantic partner to Biogen’s board
Biogen shareholders voted to add biotech executive Susan Langer, who is the romantic partner of…